| 1-naphthyl isothiocyanate | decreases expression | EXP | | 6480464 | 1-Naphthylisothiocyanate results in decreased expression of OTC mRNA | CTD | PMID:17522070 |
| 17alpha-ethynylestradiol | decreases expression | EXP | | 6480464 | Ethinyl Estradiol results in decreased expression of OTC mRNA | CTD | PMID:17108234 |
| 17beta-estradiol | decreases expression | ISO | RGD:732939 | 6480464 | Estradiol results in decreased expression of OTC mRNA | CTD | PMID:20106945 |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | RGD:11039 | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of OTC mRNA | CTD | PMID:16960034 |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of OTC mRNA | CTD | PMID:16960034 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of OTC mRNA | CTD | PMID:16960034 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of OTC mRNA | CTD | PMID:16960034 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | affects expression | EXP | | 6480464 | Tetrachlorodibenzodioxin affects the expression of OTC mRNA | CTD | PMID:22298810 |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of OTC mRNA | CTD | PMID:18796159 PMID:16960034 |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of OTC mRNA | CTD | PMID:16960034 PMID:18796159 |
| 2,4-dinitrotoluene | affects expression | EXP | | 6480464 | 2,4-dinitrotoluene affects the expression of OTC mRNA | CTD | PMID:21346803 |
| 2,6-dinitrotoluene | affects expression | EXP | | 6480464 | 2,6-dinitrotoluene affects the expression of OTC mRNA | CTD | PMID:21346803 |
| 3,3',4,4',5-pentachlorobiphenyl | decreases expression | EXP | | 6480464 | 3,4,5,3',4'-pentachlorobiphenyl results in decreased expression of OTC mRNA | CTD | PMID:20959002 |
| 6-propyl-2-thiouracil | affects expression | EXP | | 6480464 | Propylthiouracil affects the expression of OTC mRNA | CTD | PMID:19483382 |
| acetylsalicylic acid | decreases expression | ISO | RGD:732939 | 6480464 | Aspirin results in decreased expression of OTC protein | CTD | PMID:8295421 |
| aflatoxin B1 | decreases expression | ISO | RGD:11039 | 6480464 | Aflatoxin B1 results in decreased expression of OTC mRNA | CTD | PMID:19770486 |
| aflatoxin B1 | decreases expression | ISO | RGD:732939 | 6480464 | Aflatoxin B1 results in decreased expression of OTC mRNA | CTD | PMID:22100608 |
| aflatoxin B1 | affects expression | ISO | RGD:732939 | 6480464 | Aflatoxin B1 affects the expression of OTC protein | CTD | PMID:20106945 |
| amiodarone | affects expression | EXP | | 6480464 | Amiodarone affects the expression of OTC mRNA | CTD | PMID:19483382 |
| ammonia | affects metabolic processing | ISO | RGD:11039 | 6480464 | OTC protein affects the metabolism of Ammonia | CTD | PMID:16677864 |
| ammonium chloride | affects expression | EXP | | 6480464 | Ammonium Chloride affects the expression of OTC mRNA | CTD | PMID:16483693 |
| arsenic acid | increases reduction | EXP | | 6480464 | OTC protein results in increased reduction of arsenic acid | CTD | PMID:19248796 |
| benzbromarone | affects expression | EXP | | 6480464 | Benzbromarone affects the expression of OTC mRNA | CTD | PMID:19483382 |
| benzo[a]pyrene | decreases expression | ISO | RGD:11039 | 6480464 | Benzo(a)pyrene results in decreased expression of OTC mRNA | CTD | PMID:19770486 |
| benzo[a]pyrene | decreases expression | ISO | RGD:732939 | 6480464 | Benzo(a)pyrene results in decreased expression of OTC mRNA | CTD | PMID:21871943 |
| chloroform | decreases expression | EXP | | 6480464 | Chloroform results in decreased expression of OTC mRNA | CTD | PMID:17522070 |
| clofibrate | affects expression | EXP | | 6480464 | Clofibrate affects the expression of OTC mRNA | CTD | PMID:19483382 |
| cyclosporin A | decreases expression | ISO | RGD:732939 | 6480464 | Cyclosporine results in decreased expression of OTC mRNA | CTD | PMID:20106945 |
| cyclosporin A | decreases expression | ISO | RGD:11039 | 6480464 | Cyclosporine results in decreased expression of OTC mRNA | CTD | PMID:19770486 |
| dexamethasone | decreases expression | EXP | | 6480464 | Dexamethasone results in decreased expression of OTC mRNA | CTD | PMID:17522070 |
| dioxygen | decreases metabolic processing | ISO | RGD:732939 | 6480464 | Oxygen results in decreased metabolism of OTC protein | CTD | PMID:11161710 |
| dioxygen | multiple interactions | ISO | RGD:732939 | 6480464 | lactacystin inhibits the reaction [Oxygen results in decreased metabolism of OTC protein] | CTD | PMID:11161710 |
| erythromycin estolate | decreases expression | EXP | | 6480464 | Erythromycin Estolate results in decreased expression of OTC mRNA | CTD | PMID:17522070 |
| furan | affects binding | EXP | | 6480464 | furan binds to OTC protein | CTD | PMID:22240984 |
| L-ethionine | affects expression | EXP | | 6480464 | Ethionine affects the expression of OTC mRNA | CTD | PMID:19483382 |
| lactacystin | multiple interactions | ISO | RGD:732939 | 6480464 | lactacystin inhibits the reaction [Oxygen results in decreased metabolism of OTC protein] | CTD | PMID:11161710 |
| lactacystin | decreases metabolic processing | ISO | RGD:732939 | 6480464 | lactacystin results in decreased metabolism of OTC protein | CTD | PMID:11161710 |
| lead diacetate | decreases expression | EXP | | 6480464 | lead acetate results in decreased expression of OTC mRNA | CTD | PMID:11578147 |
| lead diacetate | increases expression | ISO | RGD:11039 | 6480464 | lead acetate results in increased expression of OTC mRNA | CTD | PMID:22609695 |
| N-nitrosodiethylamine | multiple interactions | EXP | | 6480464 | [Phenobarbital co-treated with Diethylnitrosamine] results in decreased expression of OTC protein | CTD | PMID:20935162 |
| naloxone | decreases expression | EXP | | 6480464 | Naloxone results in decreased expression of OTC mRNA | CTD | PMID:17522070 |
| omeprazole | affects expression | EXP | | 6480464 | Omeprazole affects the expression of OTC mRNA | CTD | PMID:19483382 |
| paracetamol | increases expression | EXP | | 6480464 | Acetaminophen results in increased expression of OTC protein | CTD | PMID:16687475 |
| paracetamol | decreases expression | EXP | | 6480464 | Acetaminophen results in decreased expression of OTC mRNA | CTD | PMID:8878780 PMID:17522070 |
| paracetamol | increases expression | ISO | RGD:11039 | 6480464 | Acetaminophen results in increased expression of OTC protein | CTD | PMID:11752693 |
| paracetamol | decreases expression | EXP | | 6480464 | Acetaminophen results in decreased expression of OTC mRNA | CTD | PMID:17522070 PMID:8878780 |
| paracetamol | affects expression | ISO | RGD:11039 | 6480464 | Acetaminophen affects the expression of OTC mRNA | CTD | PMID:17562736 |
| paraquat | decreases import | ISO | RGD:732939 | 6480464 | Paraquat results in decreased import of OTC protein | CTD | PMID:11161710 |
| paraquat | decreases metabolic processing | ISO | RGD:732939 | 6480464 | Paraquat results in decreased metabolism of OTC protein | CTD | PMID:11161710 |
| perfluorooctane-1-sulfonic acid | decreases expression | EXP | | 6480464 | perfluorooctane sulfonic acid results in decreased expression of OTC mRNA | CTD | PMID:21723365 |
| perfluorooctanoic acid | decreases expression | EXP | | 6480464 | perfluorooctanoic acid results in decreased expression of OTC mRNA | CTD | PMID:19162173 |
| perfluorooctanoic acid | decreases expression | EXP | | 6480464 | perfluorooctanoic acid results in decreased expression of OTC protein | CTD | PMID:20452409 |
| perfluorooctanoic acid | decreases expression | EXP | | 6480464 | perfluorooctanoic acid results in decreased expression of OTC mRNA | CTD | PMID:19162173 PMID:21723365 |
| phenobarbital | multiple interactions | ISO | RGD:11039 | 6480464 | NR1I3 protein affects the reaction [Phenobarbital results in decreased expression of OTC mRNA] | CTD | PMID:19482888 |
| phenobarbital | affects expression | ISO | RGD:732939 | 6480464 | Phenobarbital affects the expression of OTC mRNA | CTD | PMID:19159669 |
| phenobarbital | decreases expression | ISO | RGD:11039 | 6480464 | Phenobarbital results in decreased expression of OTC mRNA | CTD | PMID:19482888 |
| phenobarbital | multiple interactions | EXP | | 6480464 | [Phenobarbital co-treated with Diethylnitrosamine] results in decreased expression of OTC protein | CTD | PMID:20935162 |
| pirinixic acid | multiple interactions | ISO | RGD:11039 | 6480464 | [pirinixic acid co-treated with PPARA] results in decreased expression of OTC mRNA | CTD | PMID:20813756 |
| pirinixic acid | decreases expression | ISO | RGD:11039 | 6480464 | pirinixic acid results in decreased expression of OTC mRNA | CTD | PMID:20059764 more ... |
| pirinixic acid | decreases expression | ISO | RGD:11039 | 6480464 | pirinixic acid results in decreased expression of OTC mRNA | CTD | PMID:20813756 more ... |
| pirinixic acid | decreases expression | ISO | RGD:11039 | 6480464 | pirinixic acid results in decreased expression of OTC mRNA | CTD | PMID:20059764 more ... |
| pirinixic acid | affects expression | EXP | | 6480464 | pirinixic acid affects the expression of OTC mRNA | CTD | PMID:19483382 |
| pirinixic acid | decreases expression | ISO | RGD:11039 | 6480464 | pirinixic acid results in decreased expression of OTC mRNA | CTD | PMID:16807375 more ... |
| pirinixic acid | multiple interactions | ISO | RGD:11039 | 6480464 | PPARA protein promotes the reaction [pirinixic acid results in decreased expression of OTC mRNA] | CTD | PMID:20059764 |
| pirinixic acid | decreases expression | ISO | RGD:11039 | 6480464 | pirinixic acid results in decreased expression of OTC protein | CTD | PMID:16807375 |
| pirinixic acid | multiple interactions | ISO | RGD:732939 | 6480464 | [pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of OTC mRNA | CTD | PMID:19710929 |
| quinidine | decreases expression | EXP | | 6480464 | Quinidine results in decreased expression of OTC mRNA | CTD | PMID:17522070 |
| tetrachloromethane | decreases expression | EXP | | 6480464 | Carbon Tetrachloride results in decreased expression of OTC mRNA | CTD | PMID:17522070 |
| tetrachloromethane | affects expression | EXP | | 6480464 | Carbon Tetrachloride affects the expression of OTC mRNA | CTD | PMID:15963342 |
| tetracycline | decreases expression | EXP | | 6480464 | Tetracycline results in decreased expression of OTC mRNA | CTD | PMID:17522070 |
| theophylline | decreases expression | EXP | | 6480464 | Theophylline results in decreased expression of OTC mRNA | CTD | PMID:17522070 |
| thioacetamide | affects expression | EXP | | 6480464 | Thioacetamide affects the expression of OTC mRNA | CTD | PMID:19483382 |
| troglitazone | increases expression | ISO | RGD:11039 | 6480464 | troglitazone results in increased expression of OTC protein | CTD | PMID:18495193 |
| troglitazone | decreases expression | EXP | | 6480464 | troglitazone results in decreased expression of OTC protein | CTD | PMID:21315101 |
| ursodeoxycholic acid | decreases expression | EXP | | 6480464 | Ursodeoxycholic Acid results in decreased expression of OTC mRNA | CTD | PMID:15885361 |
| valproic acid | affects response to substance | ISO | RGD:732939 | 6480464 | OTC affects the susceptibility to Valproic Acid | CTD | PMID:9598692 PMID:10227223 |
| valproic acid | affects response to substance | ISO | RGD:732939 | 6480464 | OTC affects the susceptibility to Valproic Acid | CTD | PMID:10227223 PMID:9598692 |